postlisting buying in star health shares at a fair valuation or lower price is suggestedincorporated in 2006 star health is one of the largest private health insurers in india with a market share of 158 percent in fiscal 2021 primarily focusing on the retail health and group health segments which accounted for 893 percent and 107 percent of the companys total gwp gross written premium as of september 2021 its network distribution included 779 health insurance branches across 25 states and five union territoriesstar health posted losses after the pandemic leading to an increase in claims the company reported a loss of rs 38027 crore in six months to september 30 in addition to rs 82558 crore loss in fy21aprajita saxena research analyst at trustline securities said star health is one of the largest private health insurers in india with a market share of 158 per cent in fy21 has the largest distribution network diversified product suite however it has deteriorated financial metrics as indicated by losses in fy21 and h1 fy22 valuationwise star health seems overvalued in comparison to its listed peersat the higher price band of rs 900 star health is demanding a market capitalisationtonet premium earned multiple of 103x which is at premium to the peer average said choice broking